{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:57:58Z","timestamp":1791928678238,"version":"4.3.4"},"reference-count":49,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"7","license":[{"start":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T00:00:00Z","timestamp":1529884800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2018,6,25]]},"DOI":"10.1167\/iovs.18-23826","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T18:30:37Z","timestamp":1532111437000},"page":"3115","source":"Crossref","is-referenced-by-count":14,"title":["Trichostatin A Ameliorates Conjunctival Fibrosis in a Rat Trabeculectomy Model"],"prefix":"10.1167","volume":"59","author":[{"given":"Mi Sun","family":"Sung","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Research Institute of Medical Sciences, Chonnam National University Medical School and Hospital, Gwangju, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwang Hyeon","family":"Eom","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Chonnam National University Medical School, Hwasungun, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Research Institute of Medical Sciences, Chonnam National University Medical School and Hospital, Gwangju, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Young","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Research Institute of Medical Sciences, Chonnam National University Medical School and Hospital, Gwangju, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwan","family":"Heo","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Research Institute of Medical Sciences, Chonnam National University Medical School and Hospital, Gwangju, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Woo","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Research Institute of Medical Sciences, Chonnam National University Medical School and Hospital, Gwangju, South Korea"},{"name":"Center for Creative Biomedical Scientists, Chonnam National University, Gwangju, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"i1552-5783-59-7-3115-b01","doi-asserted-by":"crossref","unstructured":"Taylor HR, Keeffe JE. World blindness: a 21st century perspective. Br J Ophthalmol. 2001; 85: 261\u2013266.","DOI":"10.1136\/bjo.85.3.261"},{"key":"i1552-5783-59-7-3115-b02","doi-asserted-by":"crossref","unstructured":"Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002; 120: 1268\u20131279.","DOI":"10.1001\/archopht.120.10.1268"},{"key":"i1552-5783-59-7-3115-b03","doi-asserted-by":"crossref","unstructured":"Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol. 1998; 126: 498\u2013505.","DOI":"10.1016\/S0002-9394(98)00272-4"},{"key":"i1552-5783-59-7-3115-b04","doi-asserted-by":"crossref","unstructured":"Addicks EM, Quigley HA, Green WR, Robin AL. Histologic characteristics of filtering blebs in glaucomatous eyes. Arch Ophthalmol. 1983; 101: 795\u2013798.","DOI":"10.1001\/archopht.1983.01040010795021"},{"key":"i1552-5783-59-7-3115-b05","doi-asserted-by":"crossref","unstructured":"Seibold LK, Sherwood MB, Kahook MY. Wound modulation after filtration surgery. Surv Ophthalmol. 2012; 57: 530\u2013550.","DOI":"10.1016\/j.survophthal.2012.01.008"},{"key":"i1552-5783-59-7-3115-b06","doi-asserted-by":"crossref","unstructured":"Georgoulas S, Dahlmann-Noor A, Brocchini S, Khaw PT. Modulation of wound healing during and after glaucoma surgery. Prog Brain Res. 2008; 173: 237\u2013254.","DOI":"10.1016\/S0079-6123(08)01117-5"},{"key":"i1552-5783-59-7-3115-b07","doi-asserted-by":"crossref","unstructured":"Khaw PT, Chang L, Wong TT, et al. Modulation of wound healing after glaucoma surgery. Curr Opin Ophthalmol. 2001; 12: 143\u2013148.","DOI":"10.1097\/00055735-200104000-00011"},{"key":"i1552-5783-59-7-3115-b08","doi-asserted-by":"crossref","unstructured":"Liu L, Siriwardena D, Khaw PT. Australia and New Zealand survey of antimetabolite and steroid use in trabeculectomy surgery. J Glaucoma. 2008; 17: 423\u2013430.","DOI":"10.1097\/IJG.0b013e31816224d8"},{"key":"i1552-5783-59-7-3115-b09","doi-asserted-by":"crossref","unstructured":"Cohen JS, Greff LJ, Novack GD, Wind BE. A placebo-controlled, double-masked evaluation of mitomycin C in combined glaucoma and cataract procedures. Ophthalmology. 1996; 103: 1934\u20131942.","DOI":"10.1016\/S0161-6420(96)30405-3"},{"key":"i1552-5783-59-7-3115-b10","doi-asserted-by":"crossref","unstructured":"DeBry PW, Perkins TW, Heatley G, et al. Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol. 2002; 120: 297\u2013300.","DOI":"10.1001\/archopht.120.3.297"},{"key":"i1552-5783-59-7-3115-b11","doi-asserted-by":"crossref","unstructured":"Palanca-Capistrano AM, Hall J, Cantor LB, et al. Long-term outcomes of intraoperative 5-fluorouracil versus intraoperative mitomycin C in primary trabeculectomy surgery. Ophthalmology. 2009; 116: 185\u2013190.","DOI":"10.1016\/j.ophtha.2008.08.009"},{"key":"i1552-5783-59-7-3115-b12","doi-asserted-by":"crossref","unstructured":"Thiagalingam S, Cheng KH, Lee HJ, et al. Histone deacetylases: unique players in shaping the epigenetic histone code. Ann N Y Acad Sci. 2003; 983: 84\u2013100.","DOI":"10.1111\/j.1749-6632.2003.tb05964.x"},{"key":"i1552-5783-59-7-3115-b13","doi-asserted-by":"crossref","unstructured":"Guo W, Shan B, Klingsberg RC, et al. Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition. Am J Physiol Lung Cell Mol Physiol. 2009; 297: L864\u2013L870.","DOI":"10.1152\/ajplung.00128.2009"},{"key":"i1552-5783-59-7-3115-b14","doi-asserted-by":"crossref","unstructured":"Huber LC, Distler JH, Moritz F, et al. Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis. Arthritis Rheum. 2007; 56: 2755\u20132764.","DOI":"10.1002\/art.22759"},{"key":"i1552-5783-59-7-3115-b15","doi-asserted-by":"crossref","unstructured":"Kee HJ, Sohn IS, Nam KI, et al. Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding. Circulation. 2006; 113: 51\u201359.","DOI":"10.1161\/CIRCULATIONAHA.105.559724"},{"key":"i1552-5783-59-7-3115-b16","doi-asserted-by":"crossref","unstructured":"Pang M, Kothapally J, Mao H, et al. Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol. 2009; 297: F996\u2013F1005.","DOI":"10.1152\/ajprenal.00282.2009"},{"key":"i1552-5783-59-7-3115-b17","doi-asserted-by":"crossref","unstructured":"Sherwood MB, Esson DW, Neelakantan A, Samuelson DA. A new model of glaucoma filtering surgery in the rat. J Glaucoma. 2004; 13: 407\u2013412.","DOI":"10.1097\/01.ijg.0000131482.86547.5a"},{"key":"i1552-5783-59-7-3115-b18","doi-asserted-by":"crossref","unstructured":"Chong RS, Lee YS, Chu SWL, et al. Inhibition of monocyte chemoattractant protein 1 prevents conjunctival fibrosis in an experimental model of glaucoma filtration surgery. Invest Ophthalmol Vis Sci. 2017; 58: 3432\u20133439.","DOI":"10.1167\/iovs.17-21480"},{"key":"i1552-5783-59-7-3115-b19","unstructured":"Kitano A, Okada Y, Yamanka O, et al. Therapeutic potential of trichostatin A to control inflammatory and fibrogenic disorders of the ocular surface. Mol Vis. 2010; 16: 2964\u20132973."},{"key":"i1552-5783-59-7-3115-b20","doi-asserted-by":"crossref","unstructured":"Pauly A, Brignole-Baudouin F, Labbe A, et al. New tools for the evaluation of toxic ocular surface changes in the rat. Invest Ophthalmol Vis Sci. 2007; 48: 5473\u20135483.","DOI":"10.1167\/iovs.06-0728"},{"key":"i1552-5783-59-7-3115-b21","doi-asserted-by":"crossref","unstructured":"Sharma A, Anumanthan G, Reyes M, et al. Epigenetic modification prevents excessive wound healing and scar formation after glaucoma filtration surgery. Invest Ophthalmol Vis Sci. 2016; 57: 3381\u20133389.","DOI":"10.1167\/iovs.15-18750"},{"key":"i1552-5783-59-7-3115-b22","doi-asserted-by":"crossref","unstructured":"Van Bergen T, Zahn G, Caldirola P, et al. Integrin a5\u00df1 inhibition by CLT-28643 reduces postoperative wound healing in a mouse model of glaucoma filtration surgery. Invest Ophthalmol Vis Sci. 2016; 57: 6428\u20136439.","DOI":"10.1167\/iovs.16-19751"},{"key":"i1552-5783-59-7-3115-b23","unstructured":"Yamanaka O, Ikeda K, Saika S, et al. Gene transfer of Smad7 modulates injury-induced conjunctival wound healing in mice. Mol Vis. 2006; 12: 841\u2013851."},{"key":"i1552-5783-59-7-3115-b24","doi-asserted-by":"crossref","unstructured":"Wilson SL, Ahearne M, Hopkinson A. An overview of current techniques for ocular toxicity testing. Toxicology. 2015; 327: 32\u201346.","DOI":"10.1016\/j.tox.2014.11.003"},{"key":"i1552-5783-59-7-3115-b25","doi-asserted-by":"crossref","unstructured":"Lei D, Dong C, Wu WK, et al. Lentiviral delivery of small Hairpin RNA targeting connective tissue growth factor blocks profibrotic signaling in Tenon's capsule fibroblasts. Invest Ophthalmol Vis Sci. 2016; 57: 5171\u20135180.","DOI":"10.1167\/iovs.16-19480"},{"key":"i1552-5783-59-7-3115-b26","doi-asserted-by":"crossref","unstructured":"Sharma A, Anumanthan G, Reyes M, et al. Epigenetic modification prevents excessive wound healing and scar formation after glaucoma filtration surgery. Invest Ophthalmol Vis Sci. 2016; 57: 3381\u20133389.","DOI":"10.1167\/iovs.15-18750"},{"key":"i1552-5783-59-7-3115-b27","doi-asserted-by":"crossref","unstructured":"Chen YH, Liang CM, Chen CL, et al. Silibinin inhibits myofibroblast transdifferentiation in human tenon fibroblasts and reduces fibrosis in a rabbit trabeculectomy model. Acta Ophthalmol. 2013; 91: e506\u2013e515.","DOI":"10.1111\/aos.12160"},{"key":"i1552-5783-59-7-3115-b28","doi-asserted-by":"crossref","unstructured":"Shi H, Wang H, Fu S, et al. Losartan attenuates scar formation in filtering bleb after trabeculectomy. Invest Ophthalmol Vis Sci. 2017; 58: 1478\u20131486.","DOI":"10.1167\/iovs.16-21163"},{"key":"i1552-5783-59-7-3115-b29","doi-asserted-by":"crossref","unstructured":"Nikita E, Moulin A, Vergados I, et al. A pilot study on ocular safety and efficacy of infliximab as an antifibrotic agent after experimental glaucoma filtration surgery. Ophthalmol Ther. 2017; 6: 323\u2013334.","DOI":"10.1007\/s40123-017-0096-4"},{"key":"i1552-5783-59-7-3115-b30","doi-asserted-by":"crossref","unstructured":"Mohamed-Ahmed AHA, Lockwood A, Li H, et al. An Ilomastat-CD eye drop formulation to treat ocular scarring. Invest Ophthalmol Vis Sci. 2017; 58: 3425\u20133431.","DOI":"10.1167\/iovs.16-21377"},{"key":"i1552-5783-59-7-3115-b31","unstructured":"Yamanaka O, Saika S, Ohnishi Y, et al. Inhibition of p38MAP kinase suppresses fibrogenic reaction in conjunctiva in mice. Mol Vis. 2007; 13: 1730\u20131739."},{"key":"i1552-5783-59-7-3115-b32","doi-asserted-by":"crossref","unstructured":"Ekinci M, Cagatay HH, Ceylan E, et al. Reduction of conjunctival fibrosis after trabeculectomy using topical a-lipoic acid in rabbit eyes. J Glaucoma. 2014; 23: 372\u2013379.","DOI":"10.1097\/IJG.0000000000000052"},{"key":"i1552-5783-59-7-3115-b33","unstructured":"Jung KI, Park CK. Pirfenidone inhibits fibrosis in foreign body reaction after glaucoma drainage device implantation. Drug Des Devel Ther. 2016; 10: 1477\u20131488."},{"key":"i1552-5783-59-7-3115-b34","doi-asserted-by":"crossref","unstructured":"Cinik R, Y\u00fcksel N, Pirhan D, Aslan MS, Subasi C, Kara\u00f6z E. The effect of everolimus on scar formation in glaucoma filtering surgery in a rabbit model. Curr Eye Res. 2016; 41: 1438\u20131446.","DOI":"10.3109\/02713683.2015.1125506"},{"key":"i1552-5783-59-7-3115-b35","doi-asserted-by":"crossref","unstructured":"Gregoretti I, Lee Y-M, Goodson HV. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J Mol Biol. 2004; 338: 17\u201331.","DOI":"10.1016\/j.jmb.2004.02.006"},{"key":"i1552-5783-59-7-3115-b36","doi-asserted-by":"crossref","unstructured":"Xie M, Hill JA. HDAC-dependent ventricular remodeling. Trends Cardiovasc Med. 2013; 23: 229\u2013235.","DOI":"10.1016\/j.tcm.2012.12.006"},{"key":"i1552-5783-59-7-3115-b37","doi-asserted-by":"crossref","unstructured":"Montgomery RL, Davis CA, Potthoff MJ, et al. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev. 2007; 21: 1790\u20131802.","DOI":"10.1101\/gad.1563807"},{"key":"i1552-5783-59-7-3115-b38","doi-asserted-by":"crossref","unstructured":"Marumo T, Hishikawa K, Yoshikawa M, Hirahashi J, Kawachi S, Fujita T. Histone deacetylase modulates the proinflammatory and fibrotic changes in tubulointerstitial injury. Am J Physiol Renal Physiol. 2010; 298: F133\u2013F141.","DOI":"10.1152\/ajprenal.00400.2009"},{"key":"i1552-5783-59-7-3115-b39","doi-asserted-by":"crossref","unstructured":"Noh H, Oh EY, Seo JY, et al. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. Am J Physiol Renal Physiol. 2009; 297: F729\u2013F739.","DOI":"10.1152\/ajprenal.00086.2009"},{"key":"i1552-5783-59-7-3115-b40","unstructured":"Ye Q, Li Y, Jiang H, et al. Prevention of pulmonary fibrosis via trichostatin A (TSA) in bleomycin induced rats. Sarcoidosis Vasc Diffuse Lung Dis. 2014; 31: 219\u2013226."},{"key":"i1552-5783-59-7-3115-b41","doi-asserted-by":"crossref","unstructured":"Pang M, Kothapally J, Mao H, et al. Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy. Am J Physiol Renal Physiol. 2009; 297: F996\u2013F1005.","DOI":"10.1152\/ajprenal.00282.2009"},{"key":"i1552-5783-59-7-3115-b42","doi-asserted-by":"crossref","unstructured":"Kaimori A, Potter JJ, Choti M, Ding Z, Mezey E, Koteish AA. Histone deacetylase inhibition suppresses the transforming growth factor beta1-induced epithelial-to-mesenchymal transition in hepatocytes. Hepatology. 2010; 52: 1033\u20131045.","DOI":"10.1002\/hep.23765"},{"key":"i1552-5783-59-7-3115-b43","doi-asserted-by":"crossref","unstructured":"Rombouts K, Niki T, Greenwel P, et al. Trichostatin A, a histone deacetylase inhibitor, suppresses collagen synthesis and prevents TGF-beta(1)-induced fibrogenesis in skin fibroblasts. Exp Cell Res. 2002; 278: 184\u2013197.","DOI":"10.1006\/excr.2002.5577"},{"key":"i1552-5783-59-7-3115-b44","doi-asserted-by":"crossref","unstructured":"Gaudana R, Ananthula HK, Parenky A, Mitra AK. Ocular drug delivery. AAPS J. 2010; 12: 348\u2013360.","DOI":"10.1208\/s12248-010-9183-3"},{"key":"i1552-5783-59-7-3115-b45","doi-asserted-by":"crossref","unstructured":"Kim MS, Kwon HJ, Lee YM, et al. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med. 2001; 7: 437\u2013443.","DOI":"10.1038\/86507"},{"key":"i1552-5783-59-7-3115-b46","doi-asserted-by":"crossref","unstructured":"Inagaki Y, Okazaki I. Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut. 2007; 56: 284\u2013292.","DOI":"10.1136\/gut.2005.088690"},{"key":"i1552-5783-59-7-3115-b47","doi-asserted-by":"crossref","unstructured":"Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003; 113: 685\u2013700.","DOI":"10.1016\/S0092-8674(03)00432-X"},{"key":"i1552-5783-59-7-3115-b48","doi-asserted-by":"crossref","unstructured":"Zhang H, Dai X, Qi Y, He Y, Du W, Pang JJ. Histone deacetylases inhibitors in the treatment of retinal degenerative diseases: Overview and perspectives. J Ophthalmol. 2015; 2015: 250812.","DOI":"10.1155\/2015\/250812"},{"key":"i1552-5783-59-7-3115-b49","doi-asserted-by":"crossref","unstructured":"Fan J, Alsarraf O, Dahrouj M, et al. Inhibition of HDAC2 protects the retina from ischemic injury. Invest Ophthalmol Vis Sci. 2013; 54: 4072\u20134080.","DOI":"10.1167\/iovs.12-11529"}],"container-title":["Investigative Opthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?articleid=2686484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:30:54Z","timestamp":1791927054000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.18-23826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,25]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.18-23826","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6,25]]}}}